Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.

Neurology - 22 May 2007

Bowman G L, Kaye J A, Moore M, Waichunas D, Carlson N E, Quinn J F

Abstract excerpt

OBJECTIVE: To determine the stability and functional significance of blood-brain barrier (BBB) integrity in patients with mild to moderate Alzheimer disease (AD). METHODS: Thirty-six patients (mean age 71 +/- 7 years) with mild to moderate AD (Mini-Mental State Examination [MMSE] 19 +/- 5) partic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Albumins
Share to Apolipoproteins E
Share to Blood-Brain Barrier

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Mass Index

Share to Cerebrovascular Disorders

Share to Hypertension

Share to Longitudinal Studies

Share to Nerve Fibers, Myelinated

Source

Open in PubMed Open full text

Identifiers

PMID: 17515542
DOI: 10.1212/01.wnl.0000262031.18018.1a
PMCID: PMC2668699

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17515542-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.PMID 17515542Read ↗

Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.Semantic proximity Read ↗

Blood-Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework.Semantic proximity Read ↗

Research progress on the role and mechanism of blood-brain barrier dysfunction in Alzheimer's diseaseSemantic proximity Read ↗

Alzheimer's disease: A matter of blood-brain barrier dysfunction?Semantic proximity Read ↗

A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.Semantic proximity Read ↗

Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders.Semantic proximity Read ↗

Blood-brain barrier dysfunction in cerebral amyloid angiopathy is associated with disseminated cortical superficial siderosisSemantic proximity Read ↗

Opposing patterns of blood-brain barrier permeability and Alzheimer's disease biomarkers across APOE genotype.Semantic proximity Read ↗

Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia.Semantic proximity Read ↗

Vascular burden and Alzheimer disease pathologic progression.Semantic proximity Read ↗

Longitudinal stability of CSF tau levels in Alzheimer patients.Semantic proximity Read ↗

Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.